Economic Burden of Fungal Diseases in the United States
Author(s) -
Kaitlin Benedict,
Hilary K. Whitham,
Brendan R. Jackson
Publication year - 2022
Publication title -
open forum infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.546
H-Index - 35
ISSN - 2328-8957
DOI - 10.1093/ofid/ofac097
Subject(s) - medicine , absenteeism , environmental health , economics , management
We conservatively estimated the US economic burden of fungal diseases as $11.5 billion in 2019: direct medical costs ($7.5 billion), productivity loss due to absenteeism ($870 million), and premature deaths ($3.2 billion). An alternative “value of statistical life” approach yielded >$48 billion. These are likely underestimates given underdiagnosis and underreporting.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom